前往化源商城

Journal of Pharmacy and Pharmacology 2014-11-01

Da-Chaihu-Tang alters the pharmacokinetics of nifedipine in rats and a treatment regimen to avoid this.

Ju-Xiu He, Kenji Ohno, Jun Tang, Masao Hattori, Tadato Tani, Teruaki Akao

文献索引:J. Pharm. Pharmacol. 66(11) , 1623-30, (2014)

全文:HTML全文

摘要

To investigate the influence of co-administrated Da-Chaihu-Tang (DCT; a traditional Chinese formulation) on the pharmacokinetics of nifedipine, as well as the safe optimal dosing interval to avoid the adverse interactions.A single dose of DCT was administered with nifedipine simultaneously, 2 h before, 30 min before or 30 min after nifedipine administration. Pharmacokinetics of nifedipine with or without DCT were compared. The influences of DCT on nifedipine intestinal mucosal and hepatic metabolism were studied by using rat in-vitro everted jejunal sac model and hepatic microsomes.A simultaneous co-administration of DCT significantly increased the area under concentration-time curve from time zero to infinity (AUC0-inf ) of nifedipine. In-vitro mechanism investigations revealed that DCT inhibited both the intestinal and the hepatic metabolism of nifedipine. Further study on the optimal dosing interval for nifedipine and DCT revealed that administration of DCT 30 min before or after nifedipine did not significantly change the AUC of nifedipine.The bioavailability of nifedipine is significantly increased by a simultaneous oral co-administration of DCT. This increase is caused by the inhibitory effect of DCT on both the intestinal mucosal and the hepatic metabolism of nifedipine. The dose interval between DCT and nifedipine needs to be set for over 30 min to avoid such drug-drug interactions.© 2014 Royal Pharmaceutical Society.

相关化合物

结构式 名称/CAS号 全部文献
去氢硝苯地平 结构式 去氢硝苯地平
CAS:67035-22-7
乙酸铵 结构式 乙酸铵
CAS:631-61-8
L-赖氨酸盐酸盐 结构式 L-赖氨酸盐酸盐
CAS:657-27-2
二甲基亚砜 结构式 二甲基亚砜
CAS:67-68-5
硝苯地平 结构式 硝苯地平
CAS:21829-25-4
盐酸赖氨酸 结构式 盐酸赖氨酸
CAS:10098-89-2
8-辛酰氧基芘-1,3,6-三磺酸三钠盐 结构式 8-辛酰氧基芘-1,3,6-三磺酸三钠盐
CAS:115787-84-3